Heron Therapeutics, Inc. (HRTX)
Stock Price: $15.35 USD
-0.40 (-2.54%)
Updated Jun 17, 2021 12:36 PM EDT - Market open
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 88.64 | 146 | 77.47 | 30.77 | 1.28 | - | - | - | - | 0.65 | 1.30 | 1.26 | 0.37 | 0.41 | - | |
| Revenue Growth | -39.28% | 88.41% | 151.81% | 2305.55% | - | - | - | - | - | -50.35% | 3.17% | 241.73% | -10.44% | - | - | |
| Cost of Revenue | 36.19 | 61.62 | 27.51 | 4.59 | 0.04 | - | - | - | - | - | - | - | - | - | - | |
| Gross Profit | 52.45 | 84.35 | 49.96 | 26.18 | 1.24 | - | - | - | - | 0.65 | 1.30 | 1.26 | 0.37 | 0.41 | - | |
| Selling, General & Admin | 106 | 128 | 93.87 | 82.16 | 69.03 | 35.74 | 19.73 | 21.94 | 8.66 | 3.50 | 3.97 | 3.71 | 4.31 | 4.68 | 3.63 | |
| Research & Development | 175 | 167 | 140 | 139 | 103 | 61.18 | 54.83 | 32.52 | 15.17 | 8.21 | 7.26 | 7.80 | 19.51 | 19.36 | 15.24 | |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.12 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 281 | 295 | 234 | 221 | 172 | 96.81 | 75.48 | 54.46 | 23.83 | 11.71 | 11.24 | 11.50 | 23.81 | 24.05 | 18.86 | |
| Operating Income | -228 | -211 | -184 | -195 | -171 | -96.81 | -75.48 | -54.46 | -23.83 | -11.06 | -9.93 | -10.24 | -23.45 | -23.63 | -18.86 | |
| Interest Expense / Income | -1.73 | -5.79 | -3.29 | 2.89 | 2.22 | 0.78 | 0.89 | 0.83 | 0.61 | 0.37 | -0.24 | -0.02 | -0.59 | -1.33 | -1.01 | |
| Other Expense / Income | 0.85 | -0.16 | -1.80 | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | -1.09 | 0.38 | -2.35 | -0.07 | 0.27 | -2.19 | -23.24 | |
| Pretax Income | -227 | -205 | -179 | -197 | -173 | -97.59 | -76.37 | -55.28 | -23.35 | -11.81 | -7.35 | -10.15 | -23.13 | -20.12 | 5.39 | |
| Income Tax | - | - | - | - | - | - | - | - | - | - | - | -0.12 | - | 0.04 | 0.12 | |
| Net Income | -227 | -205 | -179 | -197 | -173 | -97.59 | -76.37 | -55.28 | -23.35 | -11.81 | -7.35 | -10.03 | -23.13 | -20.16 | 5.27 | |
| Shares Outstanding (Basic) | 90.77 | 81.78 | 73.19 | 54.04 | 37.93 | 33.08 | 26.57 | 16.16 | 12.22 | 6.01 | 1.98 | 1.63 | 1.54 | 0.97 | 0.32 | |
| Shares Outstanding (Diluted) | 90.77 | 81.78 | 73.19 | 54.04 | 37.93 | 33.08 | 26.57 | 16.16 | 12.22 | 6.01 | 1.98 | 1.63 | 1.54 | 0.97 | 0.32 | |
| Shares Change | 11% | 11.73% | 35.44% | 42.49% | 14.64% | 24.51% | 64.38% | 32.23% | 103.28% | 203.07% | 21.64% | 5.87% | 59.16% | 206.49% | - | |
| EPS (Basic) | -2.50 | -2.50 | -2.44 | -3.65 | -4.56 | -2.95 | -2.87 | -3.42 | -1.91 | -1.96 | -3.70 | -6.15 | -15.00 | -20.80 | 16.60 | |
| EPS (Diluted) | -2.50 | -2.50 | -2.44 | -3.65 | -4.56 | -2.95 | -2.87 | -3.42 | -1.91 | -1.96 | -3.70 | -6.15 | -15.00 | -20.80 | 16.60 | |
| Free Cash Flow Per Share | -2.11 | -1.61 | -2.75 | -3.20 | -3.62 | -2.40 | -2.32 | -2.63 | -1.47 | -1.37 | -2.80 | -6.75 | -15.95 | -18.35 | 28.48 | |
| Gross Margin | 59.2% | 57.8% | 64.5% | 85.1% | 97.3% | - | - | - | - | 100% | 100% | 100% | 100% | 100% | - | |
| Operating Margin | -257.4% | -144.3% | -237.4% | -632.4% | -13,363.2% | - | - | - | - | -1,712.4% | -763.6% | -812.2% | -6,353.7% | -5,736.2% | - | |
| Profit Margin | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | - | - | - | - | -1828.8% | -564.6% | -795.2% | -6266.9% | -4893.9% | - | |
| FCF Margin | -216.2% | -90.2% | -259.4% | -561.6% | -10,729.6% | - | - | - | - | -1,274.6% | -427.4% | -872.4% | -6,659.3% | -4,311.2% | - | |
| Effective Tax Rate | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.2% | |
| EBITDA | -226 | -208 | -181 | -193 | -170 | -96.07 | -74.90 | -54.12 | -22.55 | -11.26 | -7.36 | -9.82 | -23.30 | -21.09 | 4.77 | |
| EBITDA Margin | -255.2% | -142.8% | -233.1% | -627.5% | -13278% | - | - | - | - | -1743.3% | -565.5% | -778.6% | -6314.4% | -5118.7% | - | |
| EBIT | -229 | -211 | -182 | -195 | -171 | -96.81 | -75.48 | -54.46 | -22.74 | -11.44 | -7.58 | -10.17 | -23.71 | -21.45 | 4.38 | |
| EBIT Margin | -258.4% | -144.2% | -235.1% | -632.5% | -13,363.9% | - | - | - | - | -1,771.1% | -582.9% | -806.8% | -6,426.0% | -5,205.8% | - |